- Pepperdine University Hosts the 22nd Annual Celebrity Flag Football Challenge®, Presented by Todos Medical’s Tollovid®
- Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
- Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
- Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
- Todos Medical CEO Provides Letter to Shareholders
- Todos Medical to Present at January 5, 2022 Emerging Growth Conference
- Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
- Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
- Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States
- Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing
Todos Medical Ltd (TOMDF:QBB) closed at 0.0549, 243.13% above the 52 week low of 0.016 set on Aug 17, 2021.
0.016Aug 17 20210.644Jan 13 2022
|Market cap||50.20m USD|
Data delayed at least 15 minutes, as of Jan 19 2022 20:58 GMT.